Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Event, Product/Service, Trade Show

Trialbee to Highlight Patient Recruitment Advances to Support Clinical Trials During Three Sessions at Festival of Biologics

Trialbee, the leader in data and technology-based patient recruitment and enrollment for clinical trials, is leading three panels on patient recruitment and real-world data (RWD) at the Festival of Biologics, scheduled for Nov. 2-4 at Congress Center in Basel, Switzerland.

Patient recruitment is a new focus for the festival this year, along with exploring trial planning and data capture. Trialbee Strategic Advisor and Clinical Research Operations Executive Lollo Eriksson is leading the Festival of Biologics Clinical Trials track and involved in three panel discussions:

"As a global leader in software-driven patient recruitment and enrollment, Trialbee has been on the front lines of transformation across a traditionally service-oriented industry," says Eriksson, whose areas of focus include patient engagement and novel cost-effective recruitment strategies. "We are very much looking forward to creating new partnerships and tackling the challenges the Pharmaceutical industry and CROs face in clinical studies with our expertise and technology."

Prior to joining Trialbee, Eriksson spent 30 years with Merck & Co., Inc. leading clinical pharmacology, clinical research development, and clinical research operations, as well as nine years in executive leadership in CRO businesses focused on study feasibility, study startup, patient recruitment, and healthcare alliances and acquisitions.

The Festival of Biologics is billed as Europe's most exciting biologics event, bringing together pharma and biotech, academics and research institutes, and partners across the value chain to discuss the latest in biologic drug discovery, development, manufacturing, pricing and market access, and clinical trials. The festival is just one of the major Q4 industry conferences at which the company will demo Trialbee Honeytm, the company's flagship product that converts a study's potential patients into enrolled patients and provides real-time and predictive analytics from initial interest through randomization.

Trialbee will also attend and demo Trialbee Honeytm at a few other significant industry events this fall, including Outsourcing in Clinical Trials (OCT) Nordics 2022 (10/25-10/26, booth 11A) in Copenhagen, Collaborating For Novel Solutions (CNS) Summit (11/17-11/20, booth 50) in Boca Raton, Fla., and Outsourcing in Clinical Trials OCT DACH (11/30-12/1, booth 19) in Munich.

Since its launch in October 2021, Trialbee Honeytm has been used to screen well over 500,000 patients at more than 1,100 research sites in 20 countries and in 25 languages, providing unprecedented tracking and measurement of all recruitment activities while optimizing enrollment timelines through real-time analytics. Sponsors have used Trialbee Honeytm to send more than 115,000 emails and 35,000 SMS messages to patients and perform more than 20,000 telehealth qualification sessions.

"Time and again, our partner sites are improving enrollment outcomes and avoiding unnecessary delays and costs," says Trialbee CEO Matt Walz. "Our software is purpose-built for the next generation of clinical research recruitment."

To schedule a demo of Trialbee Honey, including the recently released, real-time reporting module Honey Analytics, email [email protected].

About Trialbee
Trialbee is the leading global data and technology platform for patient recruitment and enrollment in clinical trials. Trialbee Hivetm operationalizes real world data (RWD) and applies data science to find patients globally. Trialbee Honeytm simplifies the journey into clinical research for patients, reduces the burden of enrolling patients for sites and provides real-time, data-driven insights to sponsors and CROs so they can optimize enrollment timelines. Partnering with sponsors, CROs, and virtual/decentralized sites, and software providers, Trialbee is achieving patient enrollment goals and driving enhancements in diversity in clinical trial populations. We are the smartest way to match and enroll patients for your clinical trial. For more information, visit http://www.trialbee.com or contact us at [email protected].

These press releases may also interest you

at 09:05
Know Labs, Inc. , an emerging developer of non-invasive medical diagnostic technology, today announced changes to its executive leadership team. The new structure will help the Company accelerate the development and delivery of its non-invasive...

at 09:00
WHO Goodwill Ambassador for Leprosy Elimination Yohei Sasakawa had an audience with His Holiness Pope Francis at the Vatican on January 26, 2023, during which he requested the Pope's support in eliminating leprosy and the prejudice and discrimination...

at 09:00
Precision Optics Corporation, Inc. , a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today announced Dr. Joe Forkey, CEO, will present and host one-on-one meetings with investors at the...

at 09:00
Inteleos, a non-profit global healthcare certification organization, today announced the appointment of Vera M. Zlidar and Neil Sahota to its board of directors effective January 1. Zlidar serves the board with expertise in global health focusing on...

at 09:00
Dominari Holdings Inc. ("Dominari" or the "Company") today provided an update on the $2 million share repurchase program (the "Share Repurchase Program") authorized by the Company's Board of Directors on December 5, 2022....

at 08:51
The National Pressure Injury Advisory Panel (NPIAP) is pleased to be celebrating our 35th Anniversary. The organization was formed when a multidisciplinary group of 15 concerned healthcare professionals, led by Dr. Thomas P. Stewart, held their first...

News published on 25 october 2022 at 09:10 and distributed by: